Business Description
Cereno Scientific AB
ISIN : SE0008241558
Share Class Description:
FRA:4A1: BTotal Employee Number:
10Compare
Compare
Traded in other countries / regions
CRNO B.Sweden4A1.Germany IPO Date
2021-05-11Description
Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. It also evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.76 | |||||
Debt-to-EBITDA | -2.28 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -3.7 | |||||
3-Year EPS without NRI Growth Rate | -23.9 | |||||
3-Year FCF Growth Rate | 4.9 | |||||
3-Year Book Growth Rate | -17.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -13.01 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.65 | |||||
9-Day RSI | 50.45 | |||||
14-Day RSI | 48.08 | |||||
3-1 Month Momentum % | -20.37 | |||||
6-1 Month Momentum % | -36.49 | |||||
12-1 Month Momentum % | -47.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.2 | |||||
Quick Ratio | 2.2 | |||||
Cash Ratio | 2.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.2 | |||||
Shareholder Yield % | -3.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -60.14 | |||||
ROA % | -30.42 | |||||
ROIC % | -23.67 | |||||
3-Year ROIIC % | -25.33 | |||||
ROC (Joel Greenblatt) % | -2517.91 | |||||
ROCE % | -20.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 6.77 | |||||
EV-to-EBIT | -20.99 | |||||
EV-to-EBITDA | -21.2 | |||||
EV-to-Forward-Revenue | 13.85 | |||||
EV-to-FCF | -9.45 | |||||
Earnings Yield (Greenblatt) % | -4.76 | |||||
FCF Yield % | -11.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cereno Scientific AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.035 | ||
| Beta | -3.8792 | ||
| 3-Year Sharpe Ratio | 1 | ||
| 3-Year Sortino Ratio | 3.41 | ||
| Volatility % | 35.94 | ||
| 14-Day RSI | 48.08 | ||
| 14-Day ATR (€) | 0.018297 | ||
| 20-Day SMA (€) | 0.42255 | ||
| 12-1 Month Momentum % | -47.6 | ||
| 52-Week Range (€) | 0.39 - 0.9115 | ||
| Shares Outstanding (Mil) | 312.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cereno Scientific AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cereno Scientific AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-04 | In 94 days | ||
| Second quarter earnings results for 2026 | 2026-08-26 | In 24 days | ||
| General meeting for 2026 | 2026-06-17 11:00 | 0.48 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-27 | 0.52 (+0.00%) | ||
| Annual report for 2025 | 2026-05-22 | 0.48 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.60 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-27 | 0.62 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-27 | 0.85 (+0.00%) | ||
| General meeting for 2025 | 2025-06-10 11:00 | 0.96 (-0.68%) | ||
| First quarter earnings results for 2025 | 2025-05-22 | 0.92 (-5.19%) |
Show
Entries
Cereno Scientific AB Frequently Asked Questions
What is Cereno Scientific AB(FRA:4A1)'s stock price today?
The current price of FRA:4A1 is €0.43. The 52 week high of FRA:4A1 is €0.91 and 52 week low is €0.39.
When is next earnings date of Cereno Scientific AB(FRA:4A1)?
The next earnings date of Cereno Scientific AB(FRA:4A1) is 2026-08-26.
Does Cereno Scientific AB(FRA:4A1) pay dividends? If so, how much?
Cereno Scientific AB(FRA:4A1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cereno Scientific AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers